An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
The DOI matches its Crossref record; 427 of the 429 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease Key Laboratory Features of NTM Health Careand Hygiene-associated Disease Prevention Prophylaxis and Treatment of NTM Disease Introduction Methods Taxonomy Epidemiology Pathogenesis Host Defense and Immune Defects Pulmonary Disease Body Morphotype Tumor Necrosis Factor Inhibition Laboratory Procedures Collection, Digestion, Decontamination, and Staining of Specimens Respiratory Specimens Body Fluids, Abscesses, and Tissues Blood Specimen Processing Smear Microscopy Culture Techniques Incubation of NTM Cultures NTM Identification Antimicrobial Susceptibility Testing for NTM Molecular Typing Methods of NTM Clinical Presentations and Diagnostic Criteria Pulmonary Disease Cystic Fibrosis Hypersensitivity-like Disease Transplant Recipients Disseminated Disease Lymphatic Disease Skin, Soft Tissue, and Bone Disease
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Surgical excision is the recommended therapy for cervical lymphadenitis due to nontuberculous mycobacteria in children and has been associated with better outcomes than 3 months of 2-drug antibiotic therapy [62-64].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [64]
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Self-citationTelenti, A., Marchesi, F., Balz, M., Bally, F., Böttger, E. C., & Bodmer, T. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.175-178.1993 · Cited by 1,498
Epidemiology of infection by nontuberculous mycobacteria
Falkinham, J. O. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.177 · Cited by 1,113
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004) · Clinical Infectious Diseases · doi:10.1086/383317 · Cited by 977
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Mycobacterium avium Complex Infection in the Acquired Immunodeficiency Syndrome
Horsburgh, C. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241906 · Cited by 927
Research works printed but not linked: 95
- 2003, Clin Microbiol Rev, 2, 319
- 2002, Clin Chest Med, 23, 520
- 1993, J Clin Microbiol, 1, 3227
- 1977, Am Rev Respir Dis, 116, 1057
- 2001, Int J Tuberc Lung Dis, 5, 1122
- 1969, Am Rev Respir Dis, 99, 1
- 1980, J Infect Dis, 146, 829
- 1987, Am Rev Respir Dis, 135, 1007
- 1996, Semin Respir Infect, 11, 244
- 2003, Am J Respir Crit Care Med, 167, A708, 10.1164/rccm.2201090 · DOI · Paper page
- 1987, Am Rev Respir Dis, 135, 10
- 2005, Abstr Annu Meet Am Soc Microbiol, 104
- 1979, Am Rev Respir Dis, 110, 107
- 1973, Radiology, 17, 23
- 1905, Radiology, I94, 413
- 1993, Radiology, 17, 777
- 1996, Semin Respir Infect, 11, 272
- 1983, Am Rev Respir Dis, 128, 652
- 1988, Microbiol Sci, 5, 147
- 1996, MMWR Morb Mortal Wkly Rep, 45, 606
- 2002, MMWR Morb Mortal Wkly Rep, 51, 349
- 1990, J Heart Transplant, 9, 357
- 1904, Eur J Clin Microbiol Infect Dis, 13, 932
- Ann Intern Med, 109, 927
- 1990, N Engl J Med, 322, 633
- 1982, J Infect Dis, 166, 405
- 2003, J Antimicrob Chemother, 51, 1
- 1972, Am Rev Respir Dis, 105, 683
- 1984, Am J Dis Child, 13, 917
- 1994, Clin Infect Dis, 18, 1596
- 1985, Acta Cytol, 29, 732
- 1993, Acta Cytol, 37, 329
- 1968, Am Rev Respir Dis, 97, 1032
- 1980, Am Rev Respir Dis, 121, 607
- 1988, Am Rev Respir Dis, 132, 891
- 1983, Ann Intern Med, 9, 938
- 1997, N Engl J Med, 317, 197
- 1990, JAMA, 1264, 373
- 1993, J Clin Microbiol, 3, 2697
- 2003, Emerg Infect Dis, 9, 1496
- 2001, Clin Infect Dis, 31, 1506
- 1994, J Infect Dis, 169, 1166, 10.1093/infdis/169.5.1166 · DOI
- 1985, J Infect Dis, 152, 1013, 10.1093/infdis/152.5.1013 · DOI · Paper page
- 1997, Abstr Gen Meet Am Soc Microbiol, 571
- 1996, MMWR Morb Mortal Wkly Rep, 45, 713
- 2004, MMWR Morb Mortal Wkly Rep, 53, 192
- 1994, J Clin Microbiol, 37, 1193
- 1994, Am J Otol, 3, 313
- 2003, Arch Dermatol, 139, 629
- 1979, Am Rev Respir Dis, 120, 214
- 1984, Am J Respir Crit Care Med, 150, 245
- 1994, J Infect Dis, 169, 166
- 1982, Am Rev Respir Dis, 125, 388
- 2002, Int J Tuberc Lung Dis, 67, 628
- 1986, Am Rev Respir Dis, 134, 438
- 1994, Am Rev Respir Dis, 139, A399
- 1973, Am Rev Respir Dis, 108, 547
- 1987, Am Rev Respir Dis, 135, 418
- 1994, West J Med, 160, 31
- 1994, Curr Clin Top Infect Dis Chest, 14, 52
- 2000, Clin Infect Dis, 302, 288
- 1982, Am Rev Respir Dis, 126, 586
- 1991, Tubercle, 69, 47
- 1998, Ann Thorac Surg, 66, 325, 10.1016/s0003-4975(98)00401-9 · DOI
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- 1996, Clin Infect Dis, 22, 1130
- 1970, Am Rev Respir Dis, 101, 430
- 1983, Rev Epidemiol Sante Publique, 31, 11
- 1999, Int J Tuberc Lung Dis, 3, 501
- 1975, Am Rev Respir Dis, 111, 477
- 1994, Clin Infect Dis, I8, 1736
- 1967, Am Rev Respir Dis, 95, 954
- 1983, Am Rev Respir Dis, 128, 1048
- 1995, Tuber Lung Dis, 76, 104
- 1983, Antimicrob Agents Chemother, 34, 486
- 2002, 609, 151
- 1999, J Clin Microbiol, 7, 3901
- 1998, Ann Intern Med, 128, 409
- 1992, Antimicrob Agents Chemother, 36, 1987, 10.1128/aac.36.9.1987 · DOI
- 1992, Int J Med Microbiol Virol Parasitol Infect Dis, 277, 474
- 2000, AIHAJ, 61, 205, 10.1202/0002-8894(2000)061 · doi:10.1202/0002-8894(2000)061
- 1994, Clin Infect Dis, 19, 203, 10.1093/clinids/19.1.203 · DOI
- 1972, Am Rev Respir Dis, 105, 964
- 1982, J Infect Dis, 145, 9, 10.1093/infdis/145.1.9 · DOI · Paper page
- 1995, Clin Infect Dis, 30, 444
- 1992, Tubercle, 63, 279
- 2002, Clin Infect Dis, 35, 802, 10.1086/342331 · DOI
- 1980, J Infect Dis, 158, 52
- 1997, Am J Med Sci, 313, 346
- 1998, Int J Tuberc Lung Dis, 2, 258
- 1993, Am Rev Respir Dis, 128, 561
- 2003, Antimicrob Agents Chemother, 47, 1736, 10.1128/aac.47.5.1736-1738.2003 · DOI
- 2005, Bull World Health Organ, 83, 785
- 1976, Bull Int Union Tuberc Lung Dis, 51, 267
- 1981, Am Rev Respir Dis, 123, 104
Cited by
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P. C., McDonnell, M. J., Aliberti, S., Marshall, S. E., Loebinger, M. R., Murris, M., Cantón, R., Torres, A., Dimakou, K., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00629-2017 · Cited by 1,333
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
British Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,046
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00535-2020 · Cited by 924
Self-citation
Metadata
- Authors
- Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J., & Winthrop, K.
- Affiliations
- Infectious Diseases Society of America (US)
- This Official Statement of the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) was adopted by the ATS Board Of Directors, September 2006, and by the IDSA Board of Directors, January 2007
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02
- Volume
- 175
- Issue
- 4
- Pages
- 367-416
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2142447693
- Cited by
- 6,110
- References
- 427
- Citations by year
- 2026: 236 · 2025: 312 · 2024: 350 · 2023: 360 · 2022: 373 · 2021: 398 · 2020: 442 · 2019: 470 · 2018: 430 · 2017: 389 · 2016: 362 · 2015: 359 · 2014: 322 · 2013: 283 · 2012: 274
- FWCI
- 124.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Microbiology (medical) › Actinomycetales infections and treatment
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- nontuberculous mycobacteria, pulmonary NTM infection, diagnostic criteria, treatment, prevention, cystic fibrosis, transplant recipients, disseminated disease, lymphatic disorders, smear microscopy, culture techniques, antimicrobial susceptibility testing, molecular typing, tumor necrosis factor inhibition, host defense, immune defects
- MeSH terms
- Anti-Infective Agents, Bone Diseases, Disease Outbreaks, Genotype, Humans, Lung Diseases, Lymphatic Diseases, Mycobacterium Infections, Nontuberculous, Skin Diseases, Infection Control, Clinical Laboratory Techniques, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. https://app.cochat.ai/papers/10.1164/rccm.200604-571st
- The paper
- Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J., & Winthrop, K. (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200604-571st
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.